The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor

@article{Jin2015TheAP,
  title={The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor},
  author={Zeng Jin and Nana Gao and Xiao-rong Li and Yu Tang and Jie Xiong and Hong-xia Chen and Rui Xue and Yun-feng Li},
  journal={European Neuropsychopharmacology},
  year={2015},
  volume={25},
  pages={544-556}
}
Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor
TLDR
Findings indicate that LPM580153 is a novel triple reuptake inhibitor with robust antidepressant-like effects.
Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function
TLDR
It is suggested that immobility duration depends on 5-HT transporter binding levels, which lead to apparent strain differences in immobilities time in the FST and TST.
Receptor and transporter binding and activity profiles of albiflorin extracted from Radix paeoniae Alba
TLDR
Albiflorin is a novel 5-HT and NE reuptake inhibitor with high selectivity, and characterised the in vivo effect of alb iflorin on monoaminergic systems by using microanalysis.
Traditional Chinese Medicine in Depression Treatment: From Molecules to Systems
TLDR
The mechanisms of action of herbal antidepressants and their acting targets in the pathological systems in the brain, such as monoamine neurotransmissions, hypothalamic–pituitary–adrenal (HPA) axis, neurotropic factor brain-derived neurotrophic factor (BDNF) cascade, and glutamate transmission are reviewed.
Antidepressant-Like Effects of Cistanche tubulosa Extract on Chronic Unpredictable Stress Rats Through Restoration of Gut Microbiota Homeostasis
TLDR
It is shown that the application of CTE in CUS rats led to strong correlation among disrupted gut microbiota composition, hippocampus neurotransmitter levels, and production of neuroactive metabolite SCFAs, identifying CTE as a potential treatment for depressive symptoms by restoring homeostasis of gut microbiota for microbiota-gut-brain axis disorders.
GW117: A novel serotonin (5‐HT2C) receptor antagonist and melatonin (MT1/MT2) receptor agonist with potential antidepressant‐like activity in rodents
To evaluate the antidepressant‐like effect of compound GW117 in rodents using in vitro binding and uptake assays as well in vivo behavioral tests.
...
1
2
3
...

References

SHOWING 1-10 OF 38 REFERENCES
Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor
Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties
TLDR
F-98214-TA is a novel SNRI that displays greater potency than other reference antidepressants in animal models predictive of antidepressant and anxiolytic activities and was more potent than fluoxetine, venlafaxine and desipramine in most assays.
Antidepressant-Like Activity of YL-0919: A Novel Combined Selective Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist
TLDR
It is suggested that YL-0919, a novel structure compound, exerts dual effect on the serotonergic system, as both 5-HT1A receptor agonist and 5- HT uptake blocker, showing remarkable antidepressant effects in animal models, and may be used as a new option for the treatment of major depressive disorder.
The discovery of Yuanzhi-1, a triterpenoid saponin derived from the traditional Chinese medicine, has antidepressant-like activity
  • Zeng Jin, Nana Gao, +5 authors Yu Tang
  • Chemistry, Medicine
    Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2014
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
TLDR
In conclusion, S33005 interacts potently with SERTs and, less markedly, with NETs and enhances extracellular levels of 5-HT and NE throughout corticolimbic structures and selectively elevates dialysis levels of DA in frontal cortex versus subcortical regions.
The Future of Depression Psychopharmacology
TLDR
The monoamine hypothesis of depression was formulated in the mid 1960s based on the antidepressant efficacy of the monoamine reuptake inhibitors, monoamine oxidase inhibitors, and the depressogenic effects of reserpine as a monoamine depleter, but no monoamine-related finding has been found that is diagnostic for depression.
Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests?
  • M. Bourin
  • Medicine
    Fundamental & clinical pharmacology
  • 1990
TLDR
The behavioural despair test is a good complement for screening except for drugs having a beta‐agonist activity, it appears that this test is dependent on functional relationships between alpha 2 and serotononergic systems.
Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation.
TLDR
The present studies support the hypothesis that antidepressant drug action in the forced swim test involves a rapid neural adaptation as reflected by the down regulation of beta adrenergic receptors, and may serve as a model of adaptive mechanisms induced by antidepressant drugs.
...
1
2
3
4
...